News

Brickell Enters into a License Agreement with Bodor Laboratories, Inc. for Exclusive Rights to BBI-4000, a Novel, Topical Soft Anticholinergic for the Treatment of Hyperhidrosis (Excessive Sweating)

By December 1, 2012 No Comments